Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

MYSTERIOUS: Illumina | Mind Blowing Facts

Dear Illumina Stock Fans, Mark Your Calendars for September 21

Illumina stock is joining the S&P 500 on Sept. 21. Here's why that matters, what's fueling growth, and what investors should watch next.

Scale AI taps former Google Cloud executive as CEO

Scale AI taps former Google Cloud executive as CEO

Scale AI appointed Francis DeSouza as chief executive officer, effective August 10. DeSouza brings over thirty years of enterprise technology experience to the AI company. He previously led Google Cloud's security products and served as Illumina's CEO. Scale AI recently added BP and Mayo Clinic as new enterprise customers. The…

The Economic Times

US CEOs seek China business gains from Trump-Xi summit

US CEOs seek China business gains from Trump-Xi summit

American business leaders are heading to China for a summit with President Xi Jinping. They aim to resolve ongoing business challenges and secure new opportunities. Companies like Mastercard, Visa, Tesla, and BlackRock are seeking regulatory approvals and market access. The visit is seen as a political opening to accelerate discussions…

The Economic Times

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Biotech ETFs Come Alive As Illumina Soars 23% — Is The Genomics Winter Finally Over?

Biotech investors finally got a dose of good news this week. Illumina Inc (NASDAQ:ILMN) staged a powerful comeback, with the stock surging over 23% on Friday after topping its third-quarter guidance while narrowing its full-year revenue decline forecast. Now, the rally of this genomics firm has rippled through the ETF…

DNA Sequencing Firm Illumina Sees Strong Clinical Market Momentum, Stock Soars

Illumina Inc. (NASDAQ:ILMN) stock is trading higher after the company reported better-than-expected third-quarter earnings.

JPMorgan, Alibaba, Columbia Banking System And A Health Care Stock On CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades,” on Monday, Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, said JPMorgan Chase Co. (NYSE:JPM) is still his favorite financial as a long-term investor. The stock looks great, he added.

Illumina Settles With DOJ, Veterans To End Whistleblower Lawsuit

Illumina Inc. (NASDAQ:ILMN) has agreed to pay $9.8 million to resolve allegations it knowingly sold genomic sequencing systems with cybersecurity vulnerabilities to several U.S. government agencies.

inkl

Read news from The Economist, FT, and more,
with one subscription

Cathie Wood's Ark Invest Loads Up On Coinbase, Roku, Illumina, And Bitmine Immersion

Cathie Wood's Ark Invest Loads Up On Coinbase, Roku, Illumina, And Bitmine Immersion

On Friday, Cathie Wood-led Ark Invest made significant trades involving a number of prominent stocks including Coinbase Global Inc. (NASDAQ:COIN), Roku Inc. (NASDAQ:ROKU), Illumina Inc. (NASDAQ:ILMN), and Bitmine Immersion Technologies Inc. (NASDAQ:BMNR).

These Analysts Boost Their Forecasts On Illumina Following Upbeat Results

These Analysts Boost Their Forecasts On Illumina Following Upbeat Results

Illumina, Inc. (NASDAQ:ILMN) reported better-than-expected earnings for the second quarter on Thursday.

Why Cathie Wood Is Loading Up on This Hot Growth Stock (And Should You?)

Why Cathie Wood Is Loading Up on This Hot Growth Stock (And Should You?)

This dip in Illumina’s stock could be an attractive opportunity for long-term growth investors.

China Announces Tariffs On American Imports In Retaliation

China Announces Tariffs On American Imports In Retaliation

China retaliates against US tariffs with its own tariffs and export controls, including an anti-monopoly probe on Google.

Pharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers

Pharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers

The Fortune 500 pharma giant will sequence the exomes of 10 million people, with the goal of developing new therapies and more.

Experts warn DNA sequencers are vulnerable to bootkit attacks

Experts warn DNA sequencers are vulnerable to bootkit attacks

The iSeq 100 device did not come with standard boot protections, allowing crooks to establish persistence.

Dr. Oz turbocharges Medicare Advantage and everyone monitors their glucose: 10 health care predictions for 2025 from top investors

Dr. Oz turbocharges Medicare Advantage and everyone monitors their glucose: 10 health care predictions for 2025 from top investors

Although Trump is entering the White House with an electoral mandate, he will not spend any political capital on health care legislation.

Get all your
news in one place.

100's of premium titles.
One news app.

What You Need to Know Ahead of Illumina's Earnings Release

Illumina is expected to release its second-quarter earnings next month, analysts expect a double-digit earnings dip.

3 Biopharma Stocks to Buy for Long-Term Growth

With the rising investment in personalized medicine research and development and growing clinical trials, the biopharma industry’s prospects appear promising. Hence, quality biotech stocks, Alnylam Pharmaceuticals (ALNY), Illumina (ILMN), and Gilead Sciences (GILD) with long-term growth might be solid buys. Read more….

3 Biotech Stocks to Monitor for May Moves

The biotech industry is well poised to flourish, buoyed by its strong emphasis on technology-driven advancements to address complex medical challenges and government funding. Hence, quality biotech stocks Harmony Biosciences Holdings (HRMY), Illumina (ILMN), and Compugen (CGEN) could be ideal watchlist additions for May. Read more….

Illumina CFO Goswami To Depart, Dhingra To Succeed

Illumina announces CFO transition as Mr. Goswami departs and Mr. Dhingra steps in to lead the company's financial management.

Get all your
news in one place.

100's of premium titles.
One news app.

3 Biotech Stocks to Buy in 2024

The biotech industry is expected to grow rapidly due to rising demand for tailored treatments, increased R&D spending, and technological advancements. Therefore, fundamentally strong biotech stocks Harmony Biosciences Holdings (HRMY), Illumina (ILMN), and Halozyme Therapeutics (HALO) could be worth adding to your portfolio. Read on.

Court Adviser Supports Curbing Powers Of GRAIL-Illumina Merger

Legal battle between GRAIL-M-A-ILLUMINA-EU and Illumina over merger powers may reshape industry landscape and set new precedents.

Stock Indexes Climb to Record Highs on Expectations for Fed Rate Cuts

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.48%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.49%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.90%. Stocks this morning extended Wednesday’s rally, with the S&P 500, Dow Jones Industrials,...

3 B-Rated Biotech Stocks to Boost Your Bottom Line

The biotech industry’s growth prospects look promising due to innovative drugs and therapies, government initiatives, and technological advancements. Therefore, investors could consider buying fundamentally strong biotech stocks BioMarin Pharmaceutical (BMRN), Illumina (ILMN), and Harmony Biosciences (HRMY). These stocks are B-rated (Buy) in our proprietary rating system. Read on.

3 Popular Biotech Stocks to Capitalize on Gains

The biotech industry’s rapid expansion is driven by rising healthcare sending, groundbreaking innovations, and strategic collaborations, propelling the growth of biopharma companies. Thus, it could be wise to invest in popular biotech stocks Illumina (ILMN), Shionogi (SGIOY), and Regeneron Pharmaceuticals (REGN) for substantial gains. Keep reading….

3 Biotech Stocks to Buy for Profits Beyond 2024

The biotech industry is expected to deliver steady returns amid rising medical needs and increased research and development investment. Therefore, fundamentally strong biotech stocks Illumina (ILMN), Innoviva (INVA) and Puma Biotechnology (PBYI) might be ideal additions to your portfolio. Read on.

3 Biotech Stocks Investors Are Watching for Future Growth

A wide range of applications across several sectors, supportive government initiatives, rapid technological advancements, and shifting market dynamics position the biotechnology industry for robust long-term growth. Given the industry’s bright outlook, biotech stocks MannKind (MNKD), Illumina (ILMN), and TG Therapeutics (TGTX) could be ideal watchlist additions for potential growth. Read…

1 2 3 4

People

211,998 stories

Kritika SarmahHer

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

the White House

the Supreme Court

Bank of England

British Petroleum

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

415,768 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play